Correlation Between Walker Dunlop and Mydecine Innovations
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Mydecine Innovations Group, you can compare the effects of market volatilities on Walker Dunlop and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Mydecine Innovations.
Diversification Opportunities for Walker Dunlop and Mydecine Innovations
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Walker and Mydecine is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Mydecine Innovations go up and down completely randomly.
Pair Corralation between Walker Dunlop and Mydecine Innovations
Allowing for the 90-day total investment horizon Walker Dunlop is expected to under-perform the Mydecine Innovations. But the stock apears to be less risky and, when comparing its historical volatility, Walker Dunlop is 19.15 times less risky than Mydecine Innovations. The stock trades about -0.38 of its potential returns per unit of risk. The Mydecine Innovations Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 0.50 in Mydecine Innovations Group on September 24, 2024 and sell it today you would lose (0.10) from holding Mydecine Innovations Group or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Walker Dunlop vs. Mydecine Innovations Group
Performance |
| Timeline |
| Walker Dunlop |
| Mydecine Innovations |
Walker Dunlop and Mydecine Innovations Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Mydecine Innovations
The main advantage of trading using opposite Walker Dunlop and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
| Mydecine Innovations vs. Genesis Electronics Group | Mydecine Innovations vs. Nextmart | Mydecine Innovations vs. Emergent Health Corp | Mydecine Innovations vs. Goff Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |